Ivastriam

The clinical trials and research studies are a part of the work carried out by iVascular to prove the efficency and efficacy of our products.

Peripheral iVascular

Peripheral

BIBLIOS Trial

Prospective trial, single arm, multicentric study. Efficacy and safety of the BTK treatment with luminor DCB.

MERLION Trial

Prospective, non-randomized multi-center trial with luminor and angiolite BTK.

TINTIN Trial

Physician initiated, prospective, non-randomized multicenter trial, investigating the safety and efficacy of the treatment with the luminor DCB and the iVolution stent of iVascular in TASC C and D femoropopliteal atherosclerotic disease. Preliminary 6-month.

ANGIOLITE BTK Trial

Safety and feasibility study with iVascular angiolite BTK DES as bail out in BTK procedures. 6-month follow-up

EFFPAC Trial

Multicenter, randomized and controlled trial to assess the Effectiveness of luminor Paclitaxel-coated balloon catheter versus uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion. 24-month follow-up.

EVOLUTION Trial

Physician-initiated trial investigating the Efficacy of the self-expandable ivolution nitinol stent for treatment of femoropopliteal lesions. 24-month follow-up.

LUMINOR Registry

Multicentric and prospective study. Real world registry including BTK and SFA lesions. 12-month follow-up of the BTK subgroup available.

coronary iVascular

Coronary

ESSENTIAL ISR

Angiographic and optical coherence tomography assessment of the new drug-eluting balloon. 24-month follow-up.

RANGO Trial

International, multicenter, prospective and observational registry, evaluating the safety and efficacy of angiolite drug eluting stent in non-selected patients from the clinical daily practice.

ANGIOLITE Trial

Non -inferiority randomized and multicenter clinical trial to compare the efficacy and safety of angiolite versus a second-generation drug-eluting stent such as EES.

ANCHOR Trial

Multicenter, prospective and observational Trial assessing percutaneous coronary intervention with ANgiolite and Optical CoHerence TOmogrRaphy. 6 months outcomes published at Catheter Cardiovasc Interv. 2017;1-9.

Essential in in small vessels registry

International, multicenter, retrospective and observational registry, studying percutaneous coronary intervention for treating de-novo lesions in small coronary vessels with essential. Published in “Coronary Artery Disease”, Sept 2018.